Oversight of the Biden Covid-19 Administrative State Response: A Look at the Fast-Track Approval of Pfizer Vaccines
On Wednesday, June 26, 2024 at 10:00 a.m. ET, the House Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust will be holding a hearing titled “Follow the Science?: Oversight of the Biden Covid-19 Administrative State Response”. The focus of this hearing will be on the Subcommittee’s findings regarding the Biden Administration’s influence on the FDA to expedite the approval of the Pfizer COVID-19 vaccine and boosters.
During this hearing, Congress will discuss potential reforms to ensure greater accountability within the administrative state, specifically when it comes to the approval process for vaccines. This is particularly relevant given concerns about whether or not the Biden Administration pressured FDA officials to lower agency standards and approve vaccines despite reports of potential injury among young Americans. The expedited approval also led to mandates for vaccines in certain settings.
The witnesses scheduled to testify at this hearing include Dr. Philip Krause, MD, former Deputy Director of FDA Office of Vaccines Research & Review; Aaron Siri, a vaccine litigation expert; Jordan Vaughn, MD, Founder and President of Microvascular Research Foundation in Birmingham; and Andrew Tobias Pavia MD, Chief of Division Pediatric Infectious Diseases and Geographic Medicine at University of Utah School of Medicine. Each witness will provide insight and testimony regarding vaccines’ approval process and transparency/accountability in government agencies.
